These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2477368

  • 1. Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein.
    Reddy P, Caras I, Krieger M.
    J Biol Chem; 1989 Oct 15; 264(29):17329-36. PubMed ID: 2477368
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant.
    Kingsley DM, Kozarsky KF, Hobbie L, Krieger M.
    Cell; 1986 Mar 14; 44(5):749-59. PubMed ID: 3948246
    [Abstract] [Full Text] [Related]

  • 4. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM, Coyne KE.
    J Exp Med; 1991 Jul 01; 174(1):35-44. PubMed ID: 1711565
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of the signal for attachment of a glycophospholipid membrane anchor.
    Caras IW, Weddell GN, Williams SR.
    J Cell Biol; 1989 Apr 01; 108(4):1387-96. PubMed ID: 2466848
    [Abstract] [Full Text] [Related]

  • 8. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fujita T, Anstee DJ, Rosse W, Lublin DM.
    J Immunol; 1992 Nov 01; 149(9):2906-13. PubMed ID: 1383332
    [Abstract] [Full Text] [Related]

  • 9. Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment.
    Caras IW, Weddell GN.
    Science; 1989 Mar 03; 243(4895):1196-8. PubMed ID: 2466338
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression.
    Remaley AT, Ugorski M, Wu N, Litzky L, Burger SR, Moore JS, Fukuda M, Spitalnik SL.
    J Biol Chem; 1991 Dec 15; 266(35):24176-83. PubMed ID: 1748686
    [Abstract] [Full Text] [Related]

  • 12. A nonfunctional sequence converted to a signal for glycophosphatidylinositol membrane anchor attachment.
    Moran P, Caras IW.
    J Cell Biol; 1991 Oct 15; 115(2):329-36. PubMed ID: 1717483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ, Goth CK, Halim A, Vakhrushev SY, Clausen H, Petäjä-Repo UE.
    Cell Signal; 2018 Jan 15; 42():184-193. PubMed ID: 29097258
    [Abstract] [Full Text] [Related]

  • 15. Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin.
    Ravdin JI, Stanley P, Murphy CF, Petri WA.
    Infect Immun; 1989 Jul 15; 57(7):2179-86. PubMed ID: 2543634
    [Abstract] [Full Text] [Related]

  • 16. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid.
    Medof ME, Walter EI, Roberts WL, Haas R, Rosenberry TL.
    Biochemistry; 1986 Nov 04; 25(22):6740-7. PubMed ID: 2432921
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M, Seya T, Matsumoto M, Hara T, Nonaka M, Inoue N, Takeda J, Shimizu A.
    Biochem J; 1996 Mar 15; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [Abstract] [Full Text] [Related]

  • 18. Signal for attachment of a phospholipid membrane anchor in decay accelerating factor.
    Caras IW, Weddell GN, Davitz MA, Nussenzweig V, Martin DW.
    Science; 1987 Nov 27; 238(4831):1280-3. PubMed ID: 2446389
    [Abstract] [Full Text] [Related]

  • 19. Decay-accelerating factor (DAF) shares a common carbohydrate determinant with the variant surface glycoprotein (VSG) of the African Trypanosoma brucei.
    Davitz MA, Gurnett AM, Low MG, Turner MJ, Nussenzweig V.
    J Immunol; 1987 Jan 15; 138(2):520-3. PubMed ID: 2432127
    [Abstract] [Full Text] [Related]

  • 20. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
    Davitz MA, Low MG, Nussenzweig V.
    J Exp Med; 1986 May 01; 163(5):1150-61. PubMed ID: 2422313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.